Radanstobart (HFB-200603) is a humanized monoclonal antibody targeting CD272 with antitumor activity. Radanstobart is of the human IgG4κ isotype, and the recommended isotype control is Human IgG4 (S228P) kappa, Isotype Control [1].
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
















